BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24236889)

  • 1. Bifunctional oligodeoxynucleotide/antagomiR constructs: evaluation of a new tool for microRNA silencing.
    Ziegler S; Eberle ME; Wölfle SJ; Heeg K; Bekeredjian-Ding I
    Nucleic Acid Ther; 2013 Dec; 23(6):427-34. PubMed ID: 24236889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated antagomir expression.
    Surdziel E; Eder M; Scherr M
    Methods Mol Biol; 2010; 667():237-48. PubMed ID: 20827538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
    Connelly CM; Deiters A
    Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct uptake of Antagomirs and efficient knockdown of miRNA in primary B and T lymphocytes.
    Haftmann C; Riedel R; Porstner M; Wittmann J; Chang HD; Radbruch A; Mashreghi MF
    J Immunol Methods; 2015 Nov; 426():128-33. PubMed ID: 26187895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen.
    Sirotkin AV; Ovcharenko D; Grossmann R; Lauková M; Mlyncek M
    J Cell Physiol; 2009 May; 219(2):415-20. PubMed ID: 19194990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.
    Su YL; Swiderski P; Marcucci G; Kortylewski M
    Methods Mol Biol; 2019; 1974():141-150. PubMed ID: 31099000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC
    J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA knock down by cholesterol-conjugated antisense oligos in mouse organ culture.
    Kredo-Russo S; Hornstein E
    Methods Mol Biol; 2011; 732():89-97. PubMed ID: 21431707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs.
    Krieg AM; Matson S; Fisher E
    Antisense Nucleic Acid Drug Dev; 1996; 6(2):133-9. PubMed ID: 8843328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of microRNAs in vivo with 'antagomirs'.
    Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
    Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA.
    Suryawanshi H; Sarangdhar MA; Vij M; Roshan R; Singh VP; Ganguli M; Pillai B
    J Vis Exp; 2015 Dec; (106):e53307. PubMed ID: 26779762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical transfection of dye-conjugated microRNA precursors for microRNA functional analysis of M2 macrophages.
    Ng YS; Roca H; Fuller D; Sud S; Pienta KJ
    J Cell Biochem; 2012 May; 113(5):1714-23. PubMed ID: 22213010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles.
    Mui B; Raney SG; Semple SC; Hope MJ
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1185-92. PubMed ID: 11504819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing in vitro and in vivo using intronic microRNAs.
    Lin SL; Ying SY
    Methods Mol Biol; 2013; 936():209-29. PubMed ID: 23007511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.
    Xiao J; Yang B; Lin H; Lu Y; Luo X; Wang Z
    J Cell Physiol; 2007 Aug; 212(2):285-92. PubMed ID: 17516552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different chemically modified inhibitors of miR-199b in vivo.
    Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
    Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.